EVOTEC INT GMBH has a total of 31 patent applications. Its first patent ever was published in 2001. It filed its patents most often in Australia, EPO (European Patent Office) and United States. Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and biotechnology are PHOENIX PHARMALABS INC, CHAO YU-SHENG and ALEXAR THERAPEUTICS INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | Australia | 10 | |
#2 | EPO (European Patent Office) | 5 | |
#3 | United States | 4 | |
#4 | Canada | 3 | |
#5 | Brazil | 2 | |
#6 | WIPO (World Intellectual Property Organization) | 2 | |
#7 | South Africa | 2 | |
#8 | Hong Kong | 1 | |
#9 | Japan | 1 | |
#10 | Tunisia | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry | |
#3 | Biotechnology | |
#4 | Basic materials chemistry | |
#5 | Environmental technology |
# | Name | Total Patents |
---|---|---|
#1 | Blum Andreas | 12 |
#2 | Wiedenmayer Dieter | 8 |
#3 | Gottschling Dirk | 8 |
#4 | Hehn Joerg P | 7 |
#5 | Tasker Timothy | 4 |
#6 | Heckel Armin | 4 |
#7 | Kley Joerg | 4 |
#8 | Kemp John Alan | 4 |
#9 | Pinard Emmanuel | 3 |
#10 | Buettelmann Bernd | 3 |
Publication | Filing date | Title |
---|---|---|
WO2020216764A1 | Modulators of the integrated stress response pathway | |
WO2020216766A1 | Modulators of the integrated stress response pathway | |
AU2015257917A1 | Sulfoximine substituted quinazolines for pharmaceutical compositions | |
US2017174668A1 | Sulfoximine substituted quinazolines for pharmaceutical compositions |